14 April 2021 - The almost-total absence of criticism for Australia’s decision to preference Pfizer’s vaccine over AstraZeneca’s for people under 50 is remarkable.

In a single stroke, it throws Australia’s vaccine strategy into chaos. That sense of chaos will probably harm our vaccine confidence.

And the decision seems to prioritise individual risks over risks to public health.

Read Sydney Morning Herald article